35213388 29614429 29785047 30057240 30093643 30418759 30838918 30706387 33998992 32122372 32198026 31818949 34050192 30844402 31577935 31002755 31770409 31106283 33209963 30040732 33913505 34477534 32490035 30081235 31507369 33299011 29788236 3547473 - Search Results

Year	Number of Results
2018	9
2019	10
2020	10
2021	5
2022	5
2023	0

1

Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.

Negrini M, Tomasello G, Davidsson M, Fenyi A, Adant C, Hauser S, Espa E, Gubinelli F, Manfredsson FP, Melki R, Heuer A. Negrini M, et al. J Parkinsons Dis. 2022;12(4):1133-1153. doi: 10.3233/JPD-212555. J Parkinsons Dis. 2022. PMID: 35213388 Free PMC article.

2

Engineered viral vectors for functional interrogation, deconvolution, and manipulation of neural circuits.

Sun S, Schaffer DV. Sun S, et al. Curr Opin Neurobiol. 2018 Jun;50:163-170. doi: 10.1016/j.conb.2017.12.011. Epub 2018 Mar 31. Curr Opin Neurobiol. 2018. PMID: 29614429 Free PMC article. Review.

3

Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain.

Sullivan JA, Stanek LM, Lukason MJ, Bu J, Osmond SR, Barry EA, O'Riordan CR, Shihabuddin LS, Cheng SH, Scaria A. Sullivan JA, et al. Gene Ther. 2018 Jun;25(3):205-219. doi: 10.1038/s41434-018-0017-8. Epub 2018 May 22. Gene Ther. 2018. PMID: 29785047

4

Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.

Naidoo J, Stanek LM, Ohno K, Trewman S, Samaranch L, Hadaczek P, O'Riordan C, Sullivan J, San Sebastian W, Bringas JR, Snieckus C, Mahmoodi A, Mahmoodi A, Forsayeth J, Bankiewicz KS, Shihabuddin LS. Naidoo J, et al. Mol Ther. 2018 Oct 3;26(10):2418-2430. doi: 10.1016/j.ymthe.2018.07.008. Epub 2018 Jul 12. Mol Ther. 2018. PMID: 30057240 Free PMC article.

5

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Deverman BE, et al. Nat Rev Drug Discov. 2018 Sep;17(9):641-659. doi: 10.1038/nrd.2018.110. Epub 2018 Aug 10. Nat Rev Drug Discov. 2018. PMID: 30093643 Review.

6

Experimental Evaluation of Coevolution in a Self-Assembling Particle.

Hartman EC, Lobba MJ, Favor AH, Robinson SA, Francis MB, Tullman-Ercek D. Hartman EC, et al. Biochemistry. 2019 Mar 19;58(11):1527-1538. doi: 10.1021/acs.biochem.8b00948. Epub 2018 Dec 6. Biochemistry. 2019. PMID: 30418759

7

A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy.

Ingusci S, Cattaneo S, Verlengia G, Zucchini S, Simonato M. Ingusci S, et al. Epilepsy Curr. 2019 Jan;19(1):38-43. doi: 10.1177/1535759718822846. Epub 2019 Feb 12. Epilepsy Curr. 2019. PMID: 30838918 Free PMC article.

8

Basic Concepts in Viral Vector-Mediated Gene Therapy.

Benskey MJ, Sandoval IM, Miller K, Sellnow RL, Gezer A, Kuhn NC, Vashon R, Manfredsson FP. Benskey MJ, et al. Methods Mol Biol. 2019;1937:3-26. doi: 10.1007/978-1-4939-9065-8_1. Methods Mol Biol. 2019. PMID: 30706387

9

Cell-Based Delivery Approaches for DNA-Binding Domains to the Central Nervous System.

Deng P, Halmai J, Waldo JJ, Fink KD. Deng P, et al. Curr Neuropharmacol. 2021;19(12):2125-2140. doi: 10.2174/1570159X19666210517144044. Curr Neuropharmacol. 2021. PMID: 33998992 Free PMC article. Review.

10

Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.

Goodwin MS, Croft CL, Futch HS, Ryu D, Ceballos-Diaz C, Liu X, Paterno G, Mejia C, Deng D, Menezes K, Londono L, Arjona K, Parianos M, Truong V, Rostonics E, Hernandez A, Boye SL, Boye SE, Levites Y, Cruz PE, Golde TE. Goodwin MS, et al. Mol Neurodegener. 2020 Mar 2;15(1):15. doi: 10.1186/s13024-020-00361-z. Mol Neurodegener. 2020. PMID: 32122372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results